On 28 April, Fosun Pharma (the Company, stock code: 600196.SH; 02196.HK) announced its results for the first quarter of 2026 ...

ANSWER: Denosumab (Prolia) is a treatment for osteoporosis that is normally given as an injection every six months. Among its ...

I’m a 79-year-old female who’s in good health. I am 5 feet tall and weigh 95 pounds, and I’m very active. I’ve been taking Prolia for the past two to three years for osteoporosis, which has since ...

Amgen has launched a late-stage program to test the feasibility of switching patients from weekly GLP-1 injections to its own ...

AMRX targets 2027 upside through biosimilars scale, new complex launches, and Specialty recovery after 2026 Rytary erosion ...

Shanghai Henlius Biotech, Inc. (2696.HK), and Organon today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous ...

Amneal Pharmaceuticals AMRX is leaning into a playbook that can work in multiple market backdrops. The company is pairing ...

Good afternoon, everyone, and welcome to our first quarter of 2026 earnings call. Bob Bradway will lead the call today and be followed by a broader review of our performance by Murdo Gordon, Jay ...

Amgen AMGN reported first-quarter adjusted earnings of $5.15 per share, which beat the Zacks Consensus Estimate of $4.73 per ...